Rubivite

   
Google
 
Web NewDrugInformation.com

Rubivite


Drug - Rubivite
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cyanocobalamin
Multiple ingredients are in alphabetical order.

Strength - 0.03MG/ML
The potency of the active ingredient(s), Cyanocobalamin. May repeat for multiple part products.

Applicant - BEL MAR
The firm name holding legal responsibility for Rubivite. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 010791
The FDA assigned number to Rubivite. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Rubivite. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Rubivite was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Rubivite. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Rubivite is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bel Mar Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Rubivite.

Rubivite